Related Experiment Video

Updated: Nov 10, 2025

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing
09:49

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing

Published on: July 5, 2019

9.8K

A new KIF5B-ERBB4 gene fusion in a lung adenocarcinoma patient

Edouard Guenzi1, Johan Pluvy2, Alice Guyard3

  • 1Dept of Genetics, University Hospital Bichat-Claude Bernard, Paris University, Paris, France.

ERJ Open Research
|April 5, 2021
PubMed

Abstract:

https://bit.ly/3nYmGQ9.

More Related Videos

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

10.4K
Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
09:38

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on: June 26, 2019

8.2K

Related Experiment Videos

Last Updated: Nov 10, 2025

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing
09:49

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing

Published on: July 5, 2019

9.8K
A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

10.4K
Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
09:38

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on: June 26, 2019

8.2K

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

4.4K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.4K
The Ras Gene02:38

The Ras Gene

6.7K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.7K

Articles linked to this work by shared authors, journal, and citation graph.

Birt-Hogg-Dubé syndrome, prevalence of identified cases according to clinical indication in a cohort of 1,084 patients with genetic analysis.

Genetics in medicine : official journal of the American College of Medical Genetics·2026

Platelet GPVI drives fibrotic lung remodeling.

Blood advances·2026

Long-term real-world outcomes of nivolumab+ipilimumab treatment of unresectable pleural mesothelioma: update of Meso-Immune GFPC 04-2021 study.

Lung cancer (Amsterdam, Netherlands)·2026

Combined emphysema and cancer, from radiology to prognosis in patients treated by immunotherapy: An ancillary study of a prospective multicenter phase II IFCT-1802 SAVIMMUNE.

Respiratory medicine and research·2026

Diagnostic pitfalls and unmet needs in neuroendocrine neoplasms: The added value of collegial expert pathology review through the national TENpath network.

European journal of cancer (Oxford, England : 1990)·2026

External validation of the CAPAD score to predict the occurrence of clinically significant pneumothorax after CT-guided percutaneous transthoracic lung biopsy.

Respiratory medicine and research·2026

Blood remembers the lung: epigenetic signatures of severe bronchiectasis.

ERJ open research·2026

Lung function change and quantitative computed tomography measurements are associated with prospective frailty.

ERJ open research·2026

Protracted bacterial bronchitis in adults and comparison to bronchiectasis.

ERJ open research·2026

Erratum: "Effects of hypertonic saline and/or carbocisteine on sputum rheology in bronchiectasis: CLEAR-EME" Michael C. McKelvey, Gisli G. Einarsson, Jack Carson, Aram Kadoom, Ryan R. Brown, Christina Campbell, Andrew Jackson, Cliona McDowell, Mike Clarke, Fiona Copeland, Kathryn Ferguson, Rebecca H. McLeese, Rory Convery, Adam T. Hill, Anthony De Soyza, Mitra Shahidi, Martin Kelly, Mary Carroll, Timothy Gatheral, Muhammed Anwar, Jamie Duckers, William Flight, John R. Hurst, A. Alina Ionescu, Michael R. Loebinger, Anita L. Sullivan, James D. Chalmers, Damian G. Downey, Michael M. Tunney, Brenda O'Neill, Daniel F. McAuley, J. Stuart Elborn, Judy M. Bradley and Clifford C. Taggart on behalf of the CLEAR study group. ERJ Open Res 2026; 12: 00202-2026.

ERJ open research·2026

Epidemiology, risk factors and clinical outcome of community-acquired pneumonia in severely immunosuppressed patients: a comprehensive analysis from the multinational, prospective CAPNETZ Cohort.

ERJ open research·2026

Validation of a pre-flight algorithm to guide decision-making on the use of supplemental in-flight oxygen in patients with interstitial lung disease.

ERJ open research·2026

Diagnostic Discordance in a 46,XX Ovarian Dissecting Gonadoblastoma with Dysgerminoma Transformation and Leydig Cell Tumor: Hyperandrogenism, β-hCG Elevation, and CEUS Findings.

Diagnostics (Basel, Switzerland)·2026

Recurrent Mesonephric-like Adenocarcinoma of the Ovary with Bladder and Vaginal Recurrences: A Diagnostic Challenge.

Diagnostics (Basel, Switzerland)·2026

Silent Ovary with a Loud Hormonal Signal: A Case Report and Literature Review of an Androgen-Secreting Stromal Luteoma.

Journal of clinical medicine·2026

Sporadic ampullary adenoma mimicking adenocarcinoma in the absence of genetic predisposition: a case report.

Journal of surgical case reports·2026

Real-world management of ovarian cancer in women living with HIV: treatment exposure, immune monitoring, and care barriers in a five-case series.

Frontiers in oncology·2026

Lower proportion of bladder cancer diagnosed at unscheduled hospitalization after introduction of standardized care pathways in Sweden.

Scandinavian journal of urology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us